The rising popularity of XaaS-based deployment models, driven by implementations in enterprise and retail, has forced CSPs to closely examine the prospect of deploying their own support functions as a service in the cloud.
Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The companys pipeline products include
Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly known as Bellerophon Therapeutics LLC, focuses on the development of products with the combination of drugs and devices for the treatment of cardiopulmonary diseases.
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance, Inc. is a biotechnology company that develops products and therapies using cell and tissue protocols. The company performs stem cell programs which
Increasing cost pressures and growing confidence in cloud-based delivery models are driving communications service providers (CSPs) to adopt the software-as-a-service (SaaS) model for service assurance (SA). Many CSPs worldwide are
USD 1499View Report
PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)
|Published Date||:||Mar 2016|
|No. of Pages||:||25|
|Publisher||:||Analysys Mason Limited|
|Report Delivery By||:|
|Report Delivery Time||:||12 to 24 hours after placing the order.|
If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE